RaySearch Laboratories AB (publ) (RAY-B) - Net Assets

Latest as of March 2026: Skr1.04 Billion SEK ≈ $112.22 Million USD

Based on the latest financial reports, RaySearch Laboratories AB (publ) (RAY-B) has net assets worth Skr1.04 Billion SEK (≈ $112.22 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr2.03 Billion ≈ $218.20 Million USD) and total liabilities (Skr984.80 Million ≈ $105.98 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check RaySearch Laboratories AB (publ) (RAY-B) tangible equity ratio to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Skr1.04 Billion
% of Total Assets	51.43%
Annual Growth Rate	19.43%
5-Year Change	51.75%
10-Year Change	114.11%
Growth Volatility	32.8

RaySearch Laboratories AB (publ) - Net Assets Trend (2003–2025)

This chart illustrates how RaySearch Laboratories AB (publ)'s net assets have evolved over time, based on quarterly financial data. See operational self-sufficiency of RaySearch Laboratories AB (publ) to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for RaySearch Laboratories AB (publ) (2003–2025)

The table below shows the annual net assets of RaySearch Laboratories AB (publ) from 2003 to 2025. For live valuation and market cap data, see RaySearch Laboratories AB (publ) market cap and net worth.

Year	Net Assets	Change
2025-12-31	Skr985.30 Million ≈ $106.03 Million	+12.39%
2024-12-31	Skr876.71 Million ≈ $94.35 Million	+19.24%
2023-12-31	Skr735.23 Million ≈ $79.12 Million	+11.88%
2022-12-31	Skr657.16 Million ≈ $70.72 Million	+1.21%
2021-12-31	Skr649.28 Million ≈ $69.87 Million	-6.49%
2020-12-31	Skr694.35 Million ≈ $74.72 Million	-1.58%
2019-12-31	Skr705.47 Million ≈ $75.92 Million	+7.30%
2018-12-31	Skr657.45 Million ≈ $70.75 Million	+13.27%
2017-12-31	Skr580.42 Million ≈ $62.46 Million	+26.13%
2016-12-31	Skr460.19 Million ≈ $49.52 Million	+44.03%
2015-12-31	Skr319.52 Million ≈ $34.39 Million	+27.02%
2014-12-31	Skr251.55 Million ≈ $27.07 Million	+27.95%
2013-12-31	Skr196.60 Million ≈ $21.16 Million	-9.63%
2012-12-31	Skr217.55 Million ≈ $23.41 Million	+10.60%
2011-12-31	Skr196.70 Million ≈ $21.17 Million	-0.03%
2010-12-31	Skr196.76 Million ≈ $21.17 Million	+6.44%
2009-12-31	Skr184.86 Million ≈ $19.89 Million	+22.88%
2008-12-31	Skr150.44 Million ≈ $16.19 Million	+9.13%
2007-12-31	Skr137.85 Million ≈ $14.83 Million	+16.75%
2006-12-31	Skr118.07 Million ≈ $12.71 Million	+44.25%
2005-12-31	Skr81.85 Million ≈ $8.81 Million	+150.13%
2004-12-31	Skr32.72 Million ≈ $3.52 Million	+65.10%
2003-12-31	Skr19.82 Million ≈ $2.13 Million	--

Equity Component Analysis

This analysis shows how different components contribute to RaySearch Laboratories AB (publ)'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 98702300000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Retained Earnings	Skr982.00 Million	99.67%
Common Stock	Skr17.14 Million	1.74%
Other Comprehensive Income	Skr-15.80 Million	-1.60%
Other Components	Skr1.96 Million	0.20%
Total Equity	Skr985.30 Million	100.00%

RaySearch Laboratories AB (publ) Competitors by Market Cap

The table below lists competitors of RaySearch Laboratories AB (publ) ranked by their market capitalization.

Company	Market Cap
Chongqing Gangjiu Co Ltd SHG:600279	$689.49 Million
Steel Partners Holdings LP NYSE:SPLP	$689.61 Million
AFYA LTD. CL.A DL-00005 F:1AY	$689.63 Million
Ducgiang Chemicals & Detergent Powder Joint Co VN:DGC	$689.72 Million
YIT Oyj HE:YIT	$689.17 Million
Vercom SA WAR:VRC	$689.17 Million
CK Power Public Company Limited BK:CKP-R	$689.15 Million
Troax Group AB ST:TROAX	$689.11 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in RaySearch Laboratories AB (publ)'s equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 876,707,000 to 985,300,000, a change of 108,593,000 (12.4%).
Net income of 227,800,000 contributed positively to equity growth.
Dividend payments of 102,800,000 reduced retained earnings.
Other comprehensive income decreased equity by 16,462,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	Skr227.80 Million	+23.12%
Dividends Paid	Skr102.80 Million	-10.43%
Other Comprehensive Income	Skr-16.46 Million	-1.67%
Other Changes	Skr55.00K	+0.01%
Total Change	Skr-	12.39%

Book Value vs Market Value Analysis

This analysis compares RaySearch Laboratories AB (publ)'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 7.23x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 359.76x to 7.23x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2003-12-31	Skr0.58	Skr208.00	x
2004-12-31	Skr0.95	Skr208.00	x
2005-12-31	Skr2.39	Skr208.00	x
2006-12-31	Skr3.43	Skr208.00	x
2007-12-31	Skr4.00	Skr208.00	x
2008-12-31	Skr4.39	Skr208.00	x
2009-12-31	Skr5.39	Skr208.00	x
2010-12-31	Skr5.74	Skr208.00	x
2011-12-31	Skr5.74	Skr208.00	x
2012-12-31	Skr6.40	Skr208.00	x
2013-12-31	Skr5.77	Skr208.00	x
2014-12-31	Skr7.34	Skr208.00	x
2015-12-31	Skr9.32	Skr208.00	x
2016-12-31	Skr13.42	Skr208.00	x
2017-12-31	Skr16.93	Skr208.00	x
2018-12-31	Skr19.18	Skr208.00	x
2019-12-31	Skr20.58	Skr208.00	x
2020-12-31	Skr20.25	Skr208.00	x
2021-12-31	Skr18.94	Skr208.00	x
2022-12-31	Skr19.17	Skr208.00	x
2023-12-31	Skr21.45	Skr208.00	x
2024-12-31	Skr25.57	Skr208.00	x
2025-12-31	Skr28.76	Skr208.00	x

Capital Efficiency Dashboard

This dashboard shows how efficiently RaySearch Laboratories AB (publ) utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 23.12%
The company demonstrates strong efficiency in generating profits from shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 16.95%
• Asset Turnover: 0.67x
• Equity Multiplier: 2.02x
Recent ROE (23.12%) is above the historical average (13.72%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2003	-25.34%	-22.68%	0.72x	1.55x	Skr-7.01 Million
2004	39.43%	32.68%	0.87x	1.39x	Skr9.63 Million
2005	35.60%	41.72%	0.65x	1.31x	Skr20.96 Million
2006	30.68%	52.51%	0.47x	1.24x	Skr24.41 Million
2007	14.35%	30.57%	0.37x	1.26x	Skr5.99 Million
2008	12.11%	29.07%	0.33x	1.25x	Skr3.18 Million
2009	16.31%	36.02%	0.36x	1.26x	Skr11.66 Million
2010	14.69%	24.54%	0.46x	1.30x	Skr9.22 Million
2011	8.65%	13.49%	0.48x	1.33x	Skr-2.66 Million
2012	9.13%	10.91%	0.62x	1.35x	Skr-1.89 Million
2013	-10.60%	-10.19%	0.68x	1.52x	Skr-40.50 Million
2014	23.79%	20.98%	0.73x	1.55x	Skr34.68 Million
2015	21.97%	17.66%	0.82x	1.52x	Skr38.26 Million
2016	32.90%	28.49%	0.74x	1.56x	Skr105.39 Million
2017	20.27%	20.10%	0.64x	1.58x	Skr59.58 Million
2018	11.94%	12.52%	0.57x	1.68x	Skr12.78 Million
2019	7.15%	6.80%	0.59x	1.79x	Skr-20.14 Million
2020	-1.31%	-1.39%	0.51x	1.85x	Skr-78.52 Million
2021	-7.29%	-7.37%	0.37x	2.68x	Skr-112.24 Million
2022	3.62%	2.82%	0.45x	2.85x	Skr-41.94 Million
2023	11.09%	7.98%	0.52x	2.66x	Skr8.05 Million
2024	23.21%	17.07%	0.57x	2.39x	Skr115.84 Million
2025	23.12%	16.95%	0.67x	2.02x	Skr129.27 Million

Industry Comparison

This section compares RaySearch Laboratories AB (publ)'s net assets metrics with peer companies in the Health Information Services industry.

Industry Context

Industry: Health Information Services
Average net assets among peers: $23,050,219
Average return on equity (ROE) among peers: 7.94%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
RaySearch Laboratories AB (publ) (RAY-B)	Skr1.04 Billion	-25.34%	0.94x	$689.42 Million
Aino Health AB (AINO)	$1.98 Million	73.96%	3.57x	$2.69 Million
Carasent ASA (CARA)	$70.28 Million	-60.41%	1.01x	$165.12 Million
Kontigo Care AB (KONT)	$15.40 Million	-8.34%	0.59x	$5.73 Million
Medhelp Care AB (MEDHLP)	$8.68 Million	33.82%	4.47x	$22.60 Million
Physitrack PLC (PTRK)	$22.37 Million	0.41%	0.85x	$13.68 Million
Surgical Science Sweden AB (SUS)	$19.60 Million	8.16%	1.79x	$169.13 Million

About RaySearch Laboratories AB (publ)

ST:RAY-B Sweden Health Information Services

Market Cap

$689.42 Million

Skr6.41 Billion SEK

Market Cap Rank

#10800 Global

#168 in Sweden

Share Price

Skr208.00

Change (1 day)

-1.14%

52-Week Range

Skr168.40 - Skr365.50

All Time High

Skr365.50